English press releases

Samsung Introduces Its First ISOCELL Image Sensor Tailored for Automotive Applications

ISOCELL Auto 4AC is a viewing camera sensor for surround view monitors or rear-view cameras in HD resolution The sensor’s CornerPixel™ solution allows enhanced field...

Cyta deploys ADVA Oscilloquartz solution for network timing

News summary: Cyprus Telecommunications Authority required highly precise phase and time synchronization to meet demand for future high-value 5G services ADVA’s OSA 5420 Series delivers...

SES-led Consortium to Define Luxembourg’s Quantum Communication Infrastructure for Europe

Joined by InCert, itrust consulting, LuxConnect, LuxTrust and SnT, the SES-driven consortium will develop satellite-terrestrial infrastructure and the roadmap for wider European integration, setting the...

Theramex Appoints Sigurd Kirk to the Board of Directors

LONDON–(BUSINESS WIRE)– Theramex, a CVC Capital Partners (“CVC”) portfolio company focused on Women’s Health has announced that Sigurd (Sig) Kirk has been appointed as a...

Chain AMS and Link Auctions Form a Strategic Alliance

Chain AMS and Link Auctions form a strategic alliance in a bid to offer “enhanced services” to their customers. DARIEN, Conn.–(BUSINESS WIRE)– The alliance comes...

Prosus N.V.: Publication of the Prospectus and Opening of Exchange Offer

AMSTERDAM–(BUSINESS WIRE)– NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE...

Inotrem Receives Approval to Expand Nangibotide Clinical Trial in Critically Ill COVID-19 Patients and Receives Additional Public Funding of €45 Million

Inotrem’s phase 2/3 clinical trial “ESSENTIAL” will enroll up to 730 patients in Europe to demonstrate the safety and efficacy of nangibotide to treat critically...

Cristiano Ronaldo Takes Home Alipay Top Scorer Trophy at UEFA EURO 2020

HANGZHOU, China–(BUSINESS WIRE)– Portuguese football star Cristiano Ronaldo today became the winner of the Gold Trophy of the Alipay Top Scorer Awards at UEFA EURO...

New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

− Analysis of Safety and Efficacy for up to 2.5 years with TAKHYZRO is Consistent with Initial Period of Treatment, Building on Growing Body of...

Prosus Announces Shareholder Approval of Its Voluntary Share Exchange Offer

Excluding Naspers’s votes, Prosus shareholders vote 53.35% in favour of the transaction at EGM held on Friday 9 July 2021 Voluntary share exchange offer for...

The Consortium Welcomes Playtech’s Postponement of General Meeting Enabling Shareholders to Scrutinise Validity of Gopher’s Interest in Finalto

TEL AVIV, Israel–(BUSINESS WIRE)– Finalto S.P.V. Ltd, the consortium led by Barinboim Group and backed by Leumi Partners Limited and Menora Mivtachim Group, together with...

European Patient Survey finds Crohn’s Disease Patients Living with Perianal Fistulas Experience a More Significant Negative Impact on Their Quality of Life than Crohn’s Disease Patients without Perianal Fistulas

− The self-selective patient survey is one of the largest and most comprehensive surveys of its kind to explore the impact of perianal fistulas in...

Philip Morris International Inc. Announces Firm Offer to Acquire Vectura Group plc; Acquisition Accelerates PMI’s Beyond Nicotine Strategy and Expands its Product Pipeline Development Capabilities in Inhaled Therapeutics

NEW YORK–(BUSINESS WIRE)– Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has agreed with the board of Vectura Group plc (Vectura) (LSE: VEC)...

Elior Group Successfully Completes the Refinancing of Its Senior Debt, Thus Extending Its Maturity While Diversifying Its Sources of Funding

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD...

Exscientia Accelerates COVID-19 Drug Discovery Using AI

Funding from the COVID-19 Therapeutics Accelerator to advance Exscientia’s novel class of AI-designed coronavirus SARS-CoV-2 Mpro inhibitors to development candidates OXFORD, England–(BUSINESS WIRE)– Exscientia has...